Stericycle (NASDAQ:SRCL) had its target price upped by investment analysts at Royal Bank of Canada to $75.00 in a note issued to investors on Friday, The Fly reports. The brokerage presently has an “underperform” rating on the business services provider’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 4.85% from the stock’s previous close.
SRCL has been the topic of several other reports. Oppenheimer reiterated a “hold” rating on shares of Stericycle in a research note on Wednesday, December 13th. Stifel Nicolaus reiterated a “buy” rating and set a $85.00 price target on shares of Stericycle in a research note on Thursday, December 28th. Jefferies Group set a $108.00 price target on shares of Stericycle and gave the stock a “buy” rating in a research note on Tuesday, October 17th. Barrington Research dropped their price objective on shares of Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a research note on Friday, November 10th. Finally, Zacks Investment Research lowered shares of Stericycle from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $75.18.
Shares of Stericycle (NASDAQ:SRCL) opened at $71.53 on Friday. Stericycle has a one year low of $61.25 and a one year high of $88.00. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.82 and a current ratio of 0.82. The company has a market cap of $6,163.92, a price-to-earnings ratio of -125.49, a P/E/G ratio of 1.76 and a beta of 0.16.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The company had revenue of $883.00 million for the quarter, compared to analyst estimates of $896.81 million. During the same quarter in the prior year, the business earned $1.24 earnings per share. Stericycle’s revenue was down .8% compared to the same quarter last year. analysts predict that Stericycle will post 4.49 earnings per share for the current fiscal year.
In other news, Director Mark C. Miller sold 19,753 shares of the business’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $64.03, for a total transaction of $1,264,784.59. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last 90 days, insiders sold 79,012 shares of company stock worth $5,240,668. 3.50% of the stock is currently owned by company insiders.
Several institutional investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its holdings in Stericycle by 3,072.6% during the third quarter. Price T Rowe Associates Inc. MD now owns 6,294,533 shares of the business services provider’s stock worth $504,444,000 after buying an additional 6,096,128 shares in the last quarter. BlackRock Inc. boosted its holdings in Stericycle by 3,492.3% during the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock worth $421,877,000 after buying an additional 4,947,900 shares in the last quarter. Jana Partners LLC purchased a new stake in Stericycle during the first quarter worth about $305,997,000. Generation Investment Management LLP purchased a new stake in Stericycle during the second quarter worth about $237,333,000. Finally, Lateef Investment Management L.P. purchased a new stake in Stericycle during the fourth quarter worth about $195,527,000. Institutional investors and hedge funds own 94.49% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/19/stericycle-srcl-given-new-75-00-price-target-at-royal-bank-of-canada.html.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.